Suppr超能文献

肾细胞癌伴肿瘤血栓延伸至下腔静脉患者行腔静脉血栓切除术的单中心经验

Single-center experience of caval thrombectomy in patients with renal cell carcinoma with tumor thrombus extension into the inferior vena cava.

作者信息

Wang Grace J, Carpenter Jeffrey P, Fairman Ronald M, Jackson Benjamin M, Malkowicz Bruce, Van Arsdalen Keith N, Woo Edward Y

机构信息

Hospital of University of Pennsylvania, Philadelphia, Pennsylvania, USA. grace.wang@uphs. upenn.edu

出版信息

Vasc Endovascular Surg. 2008 Aug-Sep;42(4):335-40. doi: 10.1177/1538574408320525. Epub 2008 Jul 11.

Abstract

The objective of this study is to describe a single-center experience of caval thrombectomy in patients with renal cell carcinoma (RCC) and tumor thrombus extension into the inferior vena cava (IVC). We retrospectively reviewed 23 patients undergoing radical nephrectomy with caval thrombectomy. Follow-up included an office visit and computed tomography scan. Statistical comparisons were made using 2-sample t tests. Patients' ages ranged from 32 to 83 years (mean, 62 years; 18 male, 5 female). Tumor size ranged from 3 to 21 cm (mean, 8.6 cm). Tumor thrombus staging was based on the Nevus classification: level I (2/23), II (6/23), III (13/26), IV (2/23). Tumor thrombi were removed by means of digital extraction (20), Fogarty embolectomy (2), or endarterectomy (1-caval wall invasion). Lateral venorrhaphy was used for IVC repair in all cases. Hepatic mobilization and suprahepatic clamping were necessary in 14 patients. Clamp times were significantly different between the suprahepatic (SH) and infrahepatic (IH) groups (15 vs 9.4 minutes, P < .012). Mean blood loss was also significantly different (3.2 L vs 2 L, P < .045). In the SH group, 2 patients developed postoperative atrial fibrillation and 2 patients died (respiratory failure; missed enterotomy). The IH group had no perioperative morbidity or mortality. Median followup was 15 months (range, 1-54 months). Follow-up imaging was available for 19/23 patients. Ninety-five percent of patients had a patent IVC (18). One SH patient developed an IVC stenosis/thrombosis 12 months postoperatively with successful thrombolysis and stenting. There was a 16% (3/19) recurrence rate in follow-up, with all patients demonstrating renal vascular invasion and high Fuhrman grade upon final pathologic evaluation. Caval thrombectomy can be performed safely during radical nephrectomy for RCC with tumor thrombus extension. The need for suprahepatic clamping is associated with longer clamp times, increased blood loss, and increased morbidity and mortality. Lateral venorrhaphy with primary repair avoids complicated caval reconstructions and results in high patency rates, despite a not insignificant recurrence rate.

摘要

本研究的目的是描述在肾细胞癌(RCC)患者中进行腔静脉血栓切除术以及肿瘤血栓延伸至下腔静脉(IVC)的单中心经验。我们回顾性分析了23例行根治性肾切除术并进行腔静脉血栓切除术的患者。随访包括门诊就诊和计算机断层扫描。采用两样本t检验进行统计学比较。患者年龄范围为32至83岁(平均62岁;男性18例,女性5例)。肿瘤大小范围为3至21 cm(平均8.6 cm)。肿瘤血栓分期基于Nevus分类:I级(2/23),II级(6/23),III级(13/26),IV级(2/23)。通过指压取栓术(20例)、Fogarty球囊导管取栓术(2例)或动脉内膜切除术(1例,侵犯腔静脉壁)取出肿瘤血栓。所有病例均采用侧方静脉缝合术修复下腔静脉。14例患者需要进行肝脏游离和肝上阻断。肝上(SH)组和肝下(IH)组的阻断时间有显著差异(15分钟对9.4分钟,P <.012)。平均失血量也有显著差异(3.2 L对2 L,P <.045)。在SH组,2例患者术后发生心房颤动,2例患者死亡(呼吸衰竭;遗漏肠切开术)。IH组无围手术期并发症或死亡。中位随访时间为15个月(范围1至54个月)。23例患者中有19例有随访影像学资料。95%的患者下腔静脉通畅(18例)。1例SH组患者术后12个月发生下腔静脉狭窄/血栓形成,经溶栓和支架置入成功治疗。随访复发率为16%(3/19),所有患者在最终病理评估时均显示有肾血管侵犯和高Fuhrman分级。对于肿瘤血栓延伸的RCC患者,在根治性肾切除术期间可以安全地进行腔静脉血栓切除术。需要肝上阻断与更长的阻断时间、更多的失血量以及更高的并发症发生率和死亡率相关。尽管复发率不低,但采用侧方静脉缝合术进行一期修复可避免复杂的腔静脉重建,并能获得较高的通畅率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验